Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 25 citing articles:

ACE2-Independent Alternative Receptors for SARS-CoV-2
Suhyeon Lim, Monica Zhang, Theresa L. Chang
Viruses (2022) Vol. 14, Iss. 11, pp. 2535-2535
Open Access | Times Cited: 73
CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma
Jiejie Geng, Liang Chen, Yufeng Yuan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 86
SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147
Shaimaa Shouman, Nada Elkholy, Alaa E. Hussien, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry
Chuan Xu, Annie Wang, Mariana Marin, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1246-1246
Open Access | Times Cited: 54
Immune-Mediated Inflammatory Responses of Alveolar Epithelial Cells: Implications for COVID-19 Lung Pathology
Amelia Barilli, Rossana Visigalli, Francesca Ferrari, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 618-618
Open Access | Times Cited: 23
SARS-CoV-2 Receptors and Their Involvement in Cell Infection
П. П. Авдонин, E. Yu. Rybakova, S. K. Trufanov, et al.
Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology (2023) Vol. 17, Iss. 1, pp. 1-11
Open Access | Times Cited: 16
Receptors and Cofactors That Contribute to SARS-CoV-2 Entry: Can Skin Be an Alternative Route of Entry?
Manon Barthe, Leslie Hertereau, Noura Lamghari, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6253-6253
Open Access | Times Cited: 14
The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
Vadim Pivniouk, Oksana Pivniouk, Avery DeVries, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 3, pp. 923-933.e6
Open Access | Times Cited: 25
Phage-Displayed Mimotopes of SARS-CoV-2 Spike Protein Targeted to Authentic and Alternative Cellular Receptors
Valery A. Petrenko, James W. Gillespie, Laura M. De Plano, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 384-384
Open Access | Times Cited: 19
Lithium Chloride Modulates Inflammatory and Apoptotic Responses in Lung Adenocarcinoma Cells Challenged with SARS-CoV-2 S1-His Protein Recombinant
Ronald G. Pearl, Mirela Frančina, M Raymond, et al.
Research Square (Research Square) (2025)
Closed Access
SARS-CoV-2 spike protein: structure, viral entry and variants
Bing Chen, Michael Farzan, Hyeryun Choe
Nature Reviews Microbiology (2025)
Closed Access
COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and Pharmacotherapy
Lingli Xie, Ziying Zhang, Qian Wang, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 23
The Functions of SARS-CoV-2 Receptors in Diabetes-Related Severe COVID-19
Adam Drzymała
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9635-9635
Open Access | Times Cited: 3
BSG (CD147) Serum Level and Genetic Variants Are Associated with Overall Survival in Acute Myeloid Leukaemia
Piotr Łacina, Aleksandra Butrym, Eliza Turlej, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 2, pp. 332-332
Open Access | Times Cited: 12
Development of a novel human CD147 knock-in NSG mouse model to test SARS-CoV-2 viral infection
Saiaditya Badeti, Qingkui Jiang, Alireza Naghizadeh, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Brilacidin, a Non-Peptide Defensin-Mimetic Molecule, Inhibits SARS-CoV-2 Infection by Blocking Viral Entry.
Chuan Xu, Annie Wang, William Honnen, et al.
PubMed (2022) Vol. 18, Iss. 4, pp. 1-12
Closed Access | Times Cited: 11
Soluble CD147 (BSG) as a Prognostic Marker in Multiple Myeloma
Piotr Łacina, Aleksandra Butrym, Diana Frontkiewicz, et al.
Current Issues in Molecular Biology (2022) Vol. 44, Iss. 1, pp. 350-359
Open Access | Times Cited: 9
Potential Effects of Hyperglycemia on SARS-CoV-2 Entry Mechanisms in Pancreatic Beta Cells
Tara M. Michaels, M. Faadiel Essop, Danzil Joseph
Viruses (2024) Vol. 16, Iss. 8, pp. 1243-1243
Open Access | Times Cited: 1
Computational Analysis of CD46 Protein Interaction with SARS-CoV-2 Structural Proteins: Elucidating a Putative Viral Entry Mechanism into Human Cells
Pavel M. Vassiliev, Evgeni Gusev, Maria Komelkova, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2297-2297
Open Access | Times Cited: 3
AXL inhibitors selected by molecular docking: Option for reducing SARS-CoV-2 entry into cells
Octavio Galindo‐Hernández, José Luis Vique‐Sánchez
Acta Pharmaceutica (2022) Vol. 72, Iss. 3, pp. 329-343
Open Access | Times Cited: 4
Oral Epithelial Cells Expressing Low or Undetectable Levels of Human Angiotensin-Converting Enzyme 2 are Susceptible SARS-CoV-2Virus Infection in vitro
Laith Ebraham, Chuan Xu, Annie Wang, et al.
(2023)
Open Access | Times Cited: 2
Oral Epithelial Cells Expressing Low or Undetectable Levels of Human Angiotensin-Converting Enzyme 2 Are Susceptible to SARS-CoV-2 Virus Infection In Vitro
Laith Ebraham, Chuan Xu, Annie Wang, et al.
Pathogens (2023) Vol. 12, Iss. 6, pp. 843-843
Open Access | Times Cited: 2
Development of a Novel Human CD147 Knock-in NSG Mouse Model to Test SARS-CoV-2 Viral Infection
Saiaditya Badeti, Qingkui Jiang, Alireza Naghizadeh, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Packaging systems for generating SARS-CoV-2 pseudoviruses: A mini review
J. W. T. Chin, Cahyo Budiman, P L Teoh
Malaysian Journal of Microbiology (2023)
Open Access
Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant
Wanbo Tai, Benjie Chai, Shengyong Feng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top